Lysophospholipid signalling as a therapeutic target for human skin wound healing: role of GSK-3 beta/beta-catenin signalling

Darren Johnson

doi:10.1038/jid.2014.351

Lysophospholipid signalling as a therapeutic target for human skin wound healing: role of GSK-3 beta/beta-catenin signalling

Darren Johnson

Faculty of Computing, Engineering and Science

Research output: Contribution to conference › Paper › peer-review

Original language	English
DOIs	https://doi.org/10.1038/jid.2014.351
Publication status	Published - 14 Sept 2014
Event	44th Annual Meeting of the European Society for Dermatological Research. 2014, Copenhagen, Denmark: Nature Publishing Group. - Duration: 8 Sept 2014 → 14 Sept 2014

Conference

Conference	44th Annual Meeting of the European Society for Dermatological Research. 2014, Copenhagen, Denmark: Nature Publishing Group.
Period	8/09/14 → 14/09/14

Keywords

cutaneous wound healing defects
health burden
Lysophospholipid signalling
Lysophosphatidic acid
LPA treatment

Access to Document

10.1038/jid.2014.351Licence: CC BY-NC-ND

Cite this

@conference{9e6574b40e584ff79964785b4168abb5,

title = "Lysophospholipid signalling as a therapeutic target for human skin wound healing: role of GSK-3 beta/beta-catenin signalling",

keywords = "cutaneous wound healing defects , health burden, Lysophospholipid signalling , Lysophosphatidic acid, LPA treatment",

author = "Darren Johnson",

year = "2014",

month = sep,

day = "14",

doi = "10.1038/jid.2014.351",

language = "English",

note = "44th Annual Meeting of the European Society for Dermatological Research. 2014, Copenhagen, Denmark: Nature Publishing Group. ; Conference date: 08-09-2014 Through 14-09-2014",

}

TY - CONF

T1 - Lysophospholipid signalling as a therapeutic target for human skin wound healing

T2 - 44th Annual Meeting of the European Society for Dermatological Research. 2014, Copenhagen, Denmark: Nature Publishing Group.

AU - Johnson, Darren

PY - 2014/9/14

Y1 - 2014/9/14

KW - cutaneous wound healing defects

KW - health burden

KW - Lysophospholipid signalling

KW - Lysophosphatidic acid

KW - LPA treatment

U2 - 10.1038/jid.2014.351

DO - 10.1038/jid.2014.351

M3 - Paper

Y2 - 8 September 2014 through 14 September 2014

ER -